.gif)
1. Abstract
Coronavirus
disease 2019 (COVID-19 has had a deleterious effect on the world’s demographics
resulting in more than 3.8 million deaths worldwide, emerging as the most
devastating global health crisis since the era of the influenza pandemic of
1918. The main concerns regarding the disease have been lack of specific
antiviral therapies. Results from ongoing trials have given some promising
results for the management of COVID-19 especially Molnupiravir, monoclonal
antibodies, janus kinase inhibitors and remdesivir. This review article gives a
comprehensive update on various pharmacological therapies in the light of
recently published standard treatment guidelines for the management of
COVID-19.
.png)
.jpg)